Insiders Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
15.55 ^USD	-1.46%		-1.02%	-40.60%

25/04	Certain Restricted Stock Units of Tourmaline Bio, Inc. are subject to a Lock-Up Agreement Ending on 25-APR-2024.	CI
25/04	Certain Options of Tourmaline Bio, Inc. are subject to a Lock-Up Agreement Ending on 25-APR-2024.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tourmaline Bio Insider Bought Shares Worth $3,250,000, According to a Recent SEC Filing	01/02	MT
Tourmaline Bio, Inc. Appoints Clay Siegall to Serve as a Director	14/12	CI
Tourmaline Bio, Inc. Announces Resignation of Cariad Chester as Member of the Board of Directors	30/11	CI
Tourmaline Bio Insider Bought Shares Worth $280,584, According to a Recent SEC Filing	28/23/28	MT
Tourmaline Bio Insider Bought Shares Worth $110,912, According to a Recent SEC Filing	27/23/27	MT
Insider Sell: Talaris Therapeutics	15/23/15	MT
Insider Sell: Talaris Therapeutics	10/23/10	MT
Talaris Therapeutics Names Mary Kay Fenton Interim Chief Executive	26/23/26	MT
Talaris Therapeutics, Inc. Announces Executive Changes	26/23/26	CI
Talaris Therapeutics, Inc. Appoints Mary Kay Fenton as President	26/23/26	CI
Insider Sell: Talaris Therapeutics	21/23/21	MT
Insider Sell: Talaris Therapeutics	19/23/19	MT
Talaris Therapeutics, Inc. Announces the Resignation of Scott Requadt as Chief Executive Officer, Effective May 26, 2023	15/23/15	CI
Talaris Therapeutics, Inc. Announces Executive Resignation	15/23/15	CI
Insider Sell: Talaris Therapeutics	24/22/24	MT
Talaris Therapeutics, Inc. Announces Transition of Suzanne Ildstad as CSO to Being A Senior Scientific Advisor, Effective to Being A Senior Scientific Advisor	15/22/15	CI
Insider Buy: Talaris Therapeutics	03/22/03	MT
Talaris Therapeutics, Inc. Announces Board Changes	17/22/17	CI
Talaris Therapeutics, Inc. Appoints Mary Kay Fenton as Chief Financial Officer	04/21/04	CI
Talaris Therapeutics, Inc. Announces Board and Committee Appointments	29/21/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Insiders

Filters